asia healthspace

A highly heterogeneous region, Asia has established itself as one of the most exciting and challenging markets across many industries, but particularly so for healthcare products and services. Beyond price affordability issues, logistical challenges, and the regulatory labyrinths, many parts of Asia are also plagued by cultural barriers, especially for women’s health management. The lack [...]

Overview Lower limb peripheral artery disease landscape Lower limb peripheral artery disease (PAD) or peripheral vascular disease (PVD) is a cardiovascular disease that leads to narrowing and hardening of arteries found outside the coronary, aortic arch and brain.  With an estimated 10 million people in these markets who are diagnosed with lower limb PAD annually, [...]

In this post I provide for your benefit a snapshot summary of the on-going healthcare reforms being undertaken in China courtesy of a report from Ernst and Young titled “Progressions Pharma 3.0; A Global Pharmaceutical report 2010″ as well as a smart article by Wharton Business School published on March 30, 2011, on the Knowledge [...]

First of all, a big thank you to the folks at asiahealthspace.com for the warm welcome. I am very much looking forward to contributing to the space. In the next 2 – 3 years the much talked about patent cliff in the pharmaceutical industry will gain real momentum and traction. Some estimates value the impending [...]

As the world’s most populous country and fastest growing major economy, China offers many opportunities for overseas investors. The Chinese healthcare industry has considerable potential, with developed economy and strong growth in the medical device market. Yet, the market remains one of the most difficult to penetrate, due to its numerous regulations and limitations. Please [...]

Asia Healthspace extends a warm welcome to Henrik Glarbo, a highly accomplished Pharmaceutical and Medtech executive with over 20 years of experience building Healthcare businesses in Asia Pacific, from whom we anticipate valuable contributions in our pursuit of vibrant intellectual discourse in the life sciences domain. A Danish national, Henrik has lived and worked in [...]

This insightful article was provided to us by one of our contributors James J. Gillespie, President, Center for Healthcare Innovation and Brian Speicher, MBA Candidate, Sloan School of Management, MIT. “To a great extent, we have lost control of the data and, in many ways, our traditional position as information providers. Patients and others now [...]

Last week I attended a Health Informatics conference in KL. Although I met some interesting people which happened to be my primary purpose anyway, not much else of significance was learned from the conference. Well-intentioned bureaucrats describing the desperate needs to connect Health care across the delivery spectrum and how they have struggled to build [...]

We all know smaller sales forces are here to stay, rather than a passing fad or purely a function of the deep global recession. Everyone recognizes that the old pharma sales rep model is dead and has been dying for some time now. In some sense, from the perspective of being induced to undergo transformative [...]

In life, people traditionally value symmetry; symmetry of our appearance (anyone’s three wishes in life include infliction with Bell’s palsy? I think not!); symmetry of arts and architecture; and, of course, symmetry of interaction (Do unto others as you would have others do unto you). However, over the course of my professional career both in [...]